Erlotinib (Tarceva) in patients with non-small-cell lung cancer (NSCLC)): results on 394 patients from Tarceva Registr of Czech Republic

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

SKŘIČKOVÁ Jana PEŠEK Miloš ZATLOUKAL Petr KOLEK Vítězsla KOUBKOVÁ Leona SALAJKA František ZEMANOVÁ Milada TOMÍŠKOVÁ Marcela SIXTOVÁ Dimka PAVLÍK Tomáš

Year of publication 2009
Type Article in Periodical
Magazine / Source Journal of Thoracic Oncology
MU Faculty or unit

Faculty of Medicine

Citation
Field Pneumology
Keywords non-small cell ling cancer; erlotinib; Tarceva register; Czech Republic
Description 394 patients with non-small-cell lung cancer have been fed into the Erlotinib(Tarceva)register in the Czech Republic and followed up continually
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.